MedPath

IMITREX

IMITREX (sumatriptan succinate)InjectionFor Subcutaneous Use Only.

Approved
Approval ID

413cb899-509f-40cb-b898-c44af9611ce7

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 12, 2011

Manufacturers
FDA

Physicians Total Care, Inc.

DUNS: 194123980

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

sumatriptan succinate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54868-3180
Application NumberNDA020080
Product Classification
M
Marketing Category
C73594
G
Generic Name
sumatriptan succinate
Product Specifications
Route of AdministrationSUBCUTANEOUS
Effective DateDecember 12, 2011
FDA Product Classification

INGREDIENTS (3)

SUMATRIPTAN SUCCINATEActive
Quantity: 6 mg in 0.5 mL
Code: J8BDZ68989
Classification: ACTIM
SODIUM CHLORIDEInactive
Quantity: 3.5 mg in 0.5 mL
Code: 451W47IQ8X
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

IMITREX - FDA Drug Approval Details